Get started
Author

Christine E. Szarka

Observed names: C E Szarka, C Szarka, Christine E Szarka, Christine Szarka
Institution: Paoli Hospital
OpenAlex ID: A5022901686
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
2000 · G R Hudes, C E Szarka, et al. · PubMed · 97
Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.
1996 · P J O'Dwyer, C E Szarka, et al. · Journal of Clinical Investigation · 83
PDF
Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.
1995 · C E Szarka, G R Pfeiffer, et al. · PubMed · 76
Chemoprevention of cancer
1994 · Christine E. Szarka, Generosa Grana, et al. · Current Problems in Cancer · 63
Glutathione S-transferases—biomarkers of cancer risk and chemopreventive response
1998 · Margie L Clapper, Christine E Szarka · Chemico-Biological Interactions · 59
Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.
1997 · M L Clapper, C E Szarka, et al. · PubMed · 45
Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose.
2000 · P J O'Dwyer, C Szarka, et al. · PubMed · 20
Trimodality Therapy for Advanced Gallbladder Cancer
2001 · Aaron R. Sasson, John P. Hoffman, et al. · The American Surgeon · 16
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed
2002 · Nancy Lewis, Richard Scher, et al. · Cancer Chemotherapy and Pharmacology · 5
Evaluation of cognitive function and quality of life in breast cancer patients receiving adjuvant dose dense chemotherapy.
2012 · Michael B. Dabrow, Christine E. Szarka, et al. · Journal of Clinical Oncology
Works count: 10
Citation count: 464
H-index: 8
I10-index: 8
Year
Topic
Type